Compare Stocks

→ Move Your Money Before May 22 (From Stansberry Research) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
LXE Leucrotta Exploration	C$2.21	C$2.21	C$0.64 ▼ C$2.24	C$551.95M	N/A	548,019 shs	310,100 shs
PHAR Pharming Group	$9.94 -4.9%	$10.86	$9.27 ▼ $16.71	$667.07M	0.16	2,606 shs	1,466 shs
SNM ShaMaran Petroleum	C$0.08	C$0.06	C$0.04 ▼ C$0.09	C$211.50M	1.13	326,818 shs	119,145 shs
TXP Touchstone Exploration	C$0.72	C$0.84	C$0.68 ▼ C$1.53	C$168.63M	0.79	78,470 shs	49,489 shs

The Next 7 Blockbuster Stocks for Growth Investors

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
LXE Leucrotta Exploration	0.00%	0.00%	0.00%	0.00%	0.00%
PHAR Pharming Group	-2.93%	-0.16%	-11.36%	-22.01%	-11.81%
SNM ShaMaran Petroleum	0.00%	+7.14%	+25.00%	+66.67%	+7.14%
TXP Touchstone Exploration	-2.70%	-4.00%	-15.29%	-1.37%	-28.71%

Move Your Money Before May 22 (Ad)

The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals.

Here's where Dr. David Eifrig says to move your money immediately.

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
LXE Leucrotta Exploration	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
PHAR Pharming Group	2.5834 of 5 stars	3.5	5.0	0.0	0.0	2.6	0.0	0.6
SNM ShaMaran Petroleum	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
TXP Touchstone Exploration	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
LXE Leucrotta Exploration	N/A	N/A	N/A	N/A
PHAR Pharming Group	3.00	Buy	$37.00	272.23% Upside
SNM ShaMaran Petroleum	N/A	N/A	N/A	N/A
TXP Touchstone Exploration	N/A	N/A	N/A	N/A

Current Analyst Ratings

Latest PHAR, SNM, SAVP, LXE, and TXP Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
3/14/2024	PHAR Pharming Group	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$37.00

(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
LXE Leucrotta Exploration	C$44.13M	12.51	C$0.13 per share	17.68	C$1.30 per share	1.70
PHAR Pharming Group	$245.32M	2.72	$0.10 per share	100.85	$3.26 per share	3.05
SNM ShaMaran Petroleum	C$82.89M	2.55	C$0.02 per share	3.96	C$0.05 per share	1.50
TXP Touchstone Exploration	C$35.99M	4.69	C$0.03 per share	21.95	C$0.25 per share	2.88

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
LXE Leucrotta Exploration	N/A	C$0.40	5.54	∞	0.11	N/A	N/A	N/A	N/A
PHAR Pharming Group	-$10.55M	-$0.14	N/A	N/A	N/A	-4.13%	-4.53%	-2.14%	5/8/2024 (Confirmed)
SNM ShaMaran Petroleum	-C$26.71M	-C$0.01	N/A	∞	N/A	-32.22%	-17.62%	0.87%	5/8/2024 (Estimated)
TXP Touchstone Exploration	-C$20.60M	-C$0.12	N/A	∞	4.01	-57.23%	-29.82%	-10.19%	5/10/2024 (Estimated)

Latest PHAR, SNM, SAVP, LXE, and TXP Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/8/2024	N/A	PHAR Pharming Group	$0.0050	N/A	-$0.0050	N/A	N/A	N/A
3/21/2024	Q4 2023	TXP Touchstone Exploration	N/A	-C$0.12	-C$0.12	-C$0.12	N/A	C$28.26 million
3/14/2024	Q4 2023	PHAR Pharming Group	$0.05	-$0.03	-$0.08	-$0.02	$71.83 million	$81.20 million

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
LXE Leucrotta Exploration	N/A	N/A	N/A	N/A	N/A
PHAR Pharming Group	N/A	N/A	N/A	N/A	N/A
SNM ShaMaran Petroleum	N/A	N/A	N/A	N/A	N/A
TXP Touchstone Exploration	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
LXE Leucrotta Exploration	0.16	4.55	4.34
PHAR Pharming Group	0.62	4.06	3.33
SNM ShaMaran Petroleum	183.22	1.57	1.07
TXP Touchstone Exploration	54.05	0.75	0.69

Ownership

Institutional Ownership

Company	Institutional Ownership
LXE Leucrotta Exploration	N/A
PHAR Pharming Group	0.03%
SNM ShaMaran Petroleum	2.50%
TXP Touchstone Exploration	7.14%

Insider Ownership

Company	Insider Ownership
LXE Leucrotta Exploration	N/A
PHAR Pharming Group	2.07%
SNM ShaMaran Petroleum	26.20%
TXP Touchstone Exploration	8.24%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
LXE Leucrotta Exploration	16	249.75 million	N/A	Not Optionable
PHAR Pharming Group	332	67.11 million	65.72 million	Not Optionable
SNM ShaMaran Petroleum	9	2.82 billion	N/A	Not Optionable
TXP Touchstone Exploration	95	234.21 million	N/A	Not Optionable

PHAR, SNM, SAVP, LXE, and TXP Headlines

Source	Headline
	Touchstone Exploration, Inc.: Touchstone Announces Closing of Expanded Bank Facility finanznachrichten.de - April 22 at 2:29 AM
	Touchstone Announces Closing of Expanded Bank Facility finance.yahoo.com - April 22 at 2:29 AM
	Touchstone Exploration (TSE:TXP) Stock Price Down 5% marketbeat.com - April 12 at 10:53 AM
	Touchstone Exploration Full Year 2023 Earnings: EPS Misses Expectations finance.yahoo.com - March 22 at 8:19 AM
	Touchstone Exploration discusses transformational 2023 and the road ahead finance.yahoo.com - March 21 at 4:38 PM
	Stocks in play: Touchstone Exploration Inc. ca.finance.yahoo.com - March 21 at 11:32 AM
	Touchstone Exploration Stock (OTC:PBEGF) Dividends: History, Yield and Dates benzinga.com - February 24 at 9:02 AM
	Touchstone Exploration Inc. (PNW1.SG) au.finance.yahoo.com - February 20 at 3:23 PM
	FTSE 100 shares: the best opportunity in a decade to get rich? msn.com - January 28 at 4:22 AM
	Touchstone Exploration's (TSE:TXP) investors will be pleased with their solid 223% return over the last five years finance.yahoo.com - January 26 at 6:04 PM
	Touchstone Exploration Inc. Announces Notification of Major Holdings finance.yahoo.com - January 18 at 7:11 AM
	Touchstone Announces 2024 Capital Budget, Preliminary 2024 Guidance and an Operational Update finance.yahoo.com - December 19 at 3:46 AM
	Touchstone Exploration Inc. Announces 2024 Budget Guidance and Operational Update finance.yahoo.com - December 19 at 3:46 AM
	TXP:CA Touchstone Exploration Inc. seekingalpha.com - November 26 at 7:52 PM
	Touchstone Energy results show game-changing impact of Cascadura startup proactiveinvestors.com - November 14 at 9:24 AM
	Touchstone Announces Third Quarter 2023 Financial and Operating Results and Provides an Operational Update finance.yahoo.com - November 14 at 4:24 AM
	Director dealings: Touchstone Exploration CEO makes share sale sharecast.com - October 26 at 11:39 PM
	Director dealings: Everyman non-exec linked to buy, Touchstone chair sells shares sharecast.com - October 3 at 12:45 PM
	Touchstone Exploration Share Chat lse.co.uk - October 2 at 4:43 PM
	Touchstone Exploration (TSE:TXP) Could Be Struggling To Allocate Capital finance.yahoo.com - September 29 at 8:57 AM
	Touchstone Exploration put foot on the gas in Trinidad as they target 30,000 BOE and the FTSE 250 lse.co.uk - September 27 at 8:59 AM
	Touchstone’s production results are ‘very encouraging’, says Shore Cap proactiveinvestors.com - September 18 at 11:57 AM
	Touchstone Exploration quickly hits target production rate proactiveinvestors.com - September 18 at 6:57 AM
	Touchstone Exploration, Inc.: Touchstone Provides Cascadura Production Update finanznachrichten.de - September 18 at 2:20 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

3 Value Stocks Too Small For Buffett’s Portfolio
March 28, 2024 12:16 PM
View 3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Alphabet and Microsoft push Wall Street toward its first winning week in a month
April 26, 2024 3:21 AM
View Stock market today: Alphabet and Microsoft push Wall Street toward its first winning week in a month
Akebia Therapeutics Surges on FDA Approval for Anemia Treatment
April 3, 2024 9:10 AM
View Akebia Therapeutics Surges on FDA Approval for Anemia Treatment
Can Altimmune get its GLP-1 Drug to Market Before Cash Rush Out?
April 9, 2024 6:07 AM
View Can Altimmune get its GLP-1 Drug to Market Before Cash Rush Out?
Biotech Sector Nears Breakout: Will it Outperform in Q2?
April 3, 2024 6:10 AM
View Biotech Sector Nears Breakout: Will it Outperform in Q2?

All Headlines

Company Descriptions

Leucrotta Exploration

CVE:LXE

Leucrotta Exploration Inc., an oil and natural gas company, acquires, explores for, develops, and produces oil and natural gas reserves in northeastern British Columbia, Canada. As of December 31, 2021, it owned approximately 213,000 net acres of land. The company was incorporated in 2014 and is based in Calgary, Canada.

Pharming Group

NASDAQ:PHAR

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's commercialized product is RUCONEST, a plasma-free rhC1INH protein replacement therapy for the treatment acute hereditary angioedema (HAE) attacks. It also engages in the development of leniolisib for the treatment of activated phosphoinositide 3-kinase delta syndrome; OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE; and alpha-glucosidase therapy for the treatment of Pompe and fabry diseases. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. is headquartered in Leiden, the Netherlands.

ShaMaran Petroleum

CVE:SNM

ShaMaran Petroleum Corp., together with its subsidiaries, engages in the oil and gas exploration and production. It holds interest in the Atrush Block production sharing contract; and in the Sarsang Production Sharing Contract in the Kurdistan region of Iraq. The company was incorporated in 1991 and is headquartered in Vancouver, Canada.

Touchstone Exploration

TSE:TXP

Touchstone Exploration Inc. engages in the exploration, development, acquisition, production, and sale of petroleum and natural gas properties in the Republic of Trinidad and Tobago. Its primary exploration focus is the Ortoire exploration block and development production on four lease operatorship properties. The company was formerly known as Petrobank Energy and Resources Ltd. and changed its name to Touchstone Exploration Inc. in May 2014. Touchstone Exploration Inc. is headquartered in Calgary, Canada.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial